The 12 Days of Xconomists: Leading Innovators Give Their Top Advances of the Past Decade

Top Five Biomedical Innovations of the 2000s (Bob More)
Highlight: “Novartis’ imatinib (Gleevec). The first drug for specifically inhibiting an enzyme causing cancer rather than killing fast dividing cells.”

Seven Computer Science Game-Changers from the 2000s (Ed Lazowska)
Highlight: “Today, you can search more than 500 Terabytes of the Web (not to mention your own desktop) in 100 milliseconds.”

The Top Five Advances From the Decade of Genomics (Clifford Reid)
Highlight: “Advanced diagnostics by blood biomarker analysis (e.g. fetal DNA/cells in mother’s blood).”

My Top 10 List of Innovations Across the Spectrum (Larry Bock)
Highlight: “High-tech treatment of nuclear waste, a technology that solves the key bottleneck to new nuclear growth and old nuclear cleanup.”

Top Five Tech Advances of the 2000s (Steve Hall)
Highlight: “The beginning of what will likely be a permanent shift to a world of digital media.” (Also, digital camera and camera phone proliferation.)

The Decade’s Most Important Biomedical Discovery (Phillip Sharp)
Highlight: “The most important discovery of the past decade is that of ‘induced pluripotent stem cells’ or ‘iPS cells,’ which are adult cells that have been coaxed back into a embryonic-stem-cell-like state.”

The Top Five Biotech Innovations of the 2000s (Clay Siegall)
Highlight: “Cancer therapies such as Roche/Genentech’s trastuzumab (Herceptin) and Celgene’s lenalidomide (Revlimid).”

Author: Gregory T. Huang

Greg is a veteran journalist who has covered a wide range of science, technology, and business. As former editor in chief, he overaw daily news, features, and events across Xconomy's national network. Before joining Xconomy, he was a features editor at New Scientist magazine, where he edited and wrote articles on physics, technology, and neuroscience. Previously he was senior writer at Technology Review, where he reported on emerging technologies, R&D, and advances in computing, robotics, and applied physics. His writing has also appeared in Wired, Nature, and The Atlantic Monthly’s website. He was named a New York Times professional fellow in 2003. Greg is the co-author of Guanxi (Simon & Schuster, 2006), about Microsoft in China and the global competition for talent and technology. Before becoming a journalist, he did research at MIT’s Artificial Intelligence Lab. He has published 20 papers in scientific journals and conferences and spoken on innovation at Adobe, Amazon, eBay, Google, HP, Microsoft, Yahoo, and other organizations. He has a Master’s and Ph.D. in electrical engineering and computer science from MIT, and a B.S. in electrical engineering from the University of Illinois, Urbana-Champaign.